These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 26873095)

  • 1. Implantable cardioverter-defibrillators in adults with congenital heart disease: a systematic review and meta-analysis.
    Vehmeijer JT; Brouwer TF; Limpens J; Knops RE; Bouma BJ; Mulder BJ; de Groot JR
    Eur Heart J; 2016 May; 37(18):1439-48. PubMed ID: 26873095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of implantable cardioverter-defibrillators in adult congenital heart disease patients: indications and outcomes.
    Santharam S; Hudsmith L; Thorne S; Clift P; Marshall H; De Bono J
    Europace; 2017 Mar; 19(3):407-413. PubMed ID: 27234868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defibrillators in adult congenital heart disease: Long-term risk of appropriate shocks, inappropriate shocks, and complications.
    Moore BM; Cao J; Cordina RL; McGuire MA; Celermajer DS
    Pacing Clin Electrophysiol; 2020 Jul; 43(7):746-753. PubMed ID: 32495949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lesion-specific differences for implantable cardioverter defibrillator therapies in adults with congenital heart disease.
    Kella DK; Merchant FM; Veledar E; Book W; Lloyd MS
    Pacing Clin Electrophysiol; 2014 Nov; 37(11):1492-8. PubMed ID: 24889130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of patients at risk of sudden cardiac death in congenital heart disease: The PRospEctiVE study on implaNTable cardIOverter defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease (PREVENTION-ACHD).
    Vehmeijer JT; Koyak Z; Leerink JM; Zwinderman AH; Harris L; Peinado R; Oechslin EN; Robbers-Visser D; Groenink M; Boekholdt SM; de Winter RJ; Oliver JM; Bouma BJ; Budts W; Van Gelder IC; Mulder BJM; de Groot JR
    Heart Rhythm; 2021 May; 18(5):785-792. PubMed ID: 33465514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
    Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality and appropriate and inappropriate therapy in patients with ischaemic heart disease and implanted cardioverter-defibrillators for primary prevention: data from the Danish ICD Register.
    Weeke P; Johansen JB; Jørgensen OD; Nielsen JC; Møller M; Videbæk R; Højgaard MV; Riahi S; Jacobsen PK
    Europace; 2013 Aug; 15(8):1150-7. PubMed ID: 23407630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic Review and Meta-Analysis of Clinical Outcome After Implantable Cardioverter-Defibrillator Therapy in Patients With Chagas Heart Disease.
    Rassi FM; Minohara L; Rassi A; Correia LCL; Marin-Neto JA; Rassi A; da Silva Menezes A
    JACC Clin Electrophysiol; 2019 Oct; 5(10):1213-1223. PubMed ID: 31648747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of adult patients with congenital heart disease and an implantable cardioverter defibrillator.
    Coutinho Cruz M; Viveiros Monteiro A; Portugal G; Laranjo S; Lousinha A; Valente B; Osório P; Silva Cunha P; de Sousa L; Oliveira JA; Agapito A; Martins Oliveira M; Pinto F; Cruz Ferreira R
    Congenit Heart Dis; 2019 Jul; 14(4):525-533. PubMed ID: 30889316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable cardioverter-defibrillator therapy to reduce sudden cardiac death in adults with congenital heart disease: A registry study.
    Slater TA; Cupido B; Parry H; Drozd M; Blackburn ME; Hares D; Pepper CB; Birkitt L; Cullington D; Witte KK; Oliver J; English KM; Sengupta A
    J Cardiovasc Electrophysiol; 2020 Aug; 31(8):2086-2092. PubMed ID: 32583559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter defibrillator therapy in adults with congenital heart disease: who is at risk of shocks?
    Koyak Z; de Groot JR; Van Gelder IC; Bouma BJ; van Dessel PF; Budts W; van Erven L; van Dijk AP; Wilde AA; Pieper PG; Sieswerda GT; Mulder BJ
    Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):101-10. PubMed ID: 22095638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Adults With Congenital Heart Disease.
    Moore JP; Mondésert B; Lloyd MS; Cook SC; Zaidi AN; Pass RH; John AS; Fish FA; Shannon KM; Aboulhosn JA; Khairy P;
    Circ Arrhythm Electrophysiol; 2016 Sep; 9(9):. PubMed ID: 27635073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transvenous and non-transvenous implantable cardioverter-defibrillators in children, adolescents, and adults with congenital heart disease: who is at risk for appropriate and inappropriate shocks?
    Krause U; Müller MJ; Wilberg Y; Pietzka M; Backhoff D; Ruschewski W; Paul T
    Europace; 2019 Jan; 21(1):106-113. PubMed ID: 30339209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable cardioverter-defibrillators in tetralogy of Fallot.
    Khairy P; Harris L; Landzberg MJ; Viswanathan S; Barlow A; Gatzoulis MA; Fernandes SM; Beauchesne L; Therrien J; Chetaille P; Gordon E; Vonder Muhll I; Cecchin F
    Circulation; 2008 Jan; 117(3):363-70. PubMed ID: 18172030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-center experience with implantable cardioverter-defibrillators in adults with complex congenital heart disease.
    Khanna AD; Warnes CA; Phillips SD; Lin G; Brady PA
    Am J Cardiol; 2011 Sep; 108(5):729-34. PubMed ID: 21684513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of Sudden Cardiac Death in Adults With Congenital Heart Disease: Do the Guidelines Fall Short?
    Vehmeijer JT; Koyak Z; Budts W; Harris L; Silversides CK; Oechslin EN; Bouma BJ; Zwinderman AH; Mulder BJM; de Groot JR
    Circ Arrhythm Electrophysiol; 2017 Jul; 10(7):. PubMed ID: 28696220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midterm Results of Implantable Cardioverter Defibrillators in Children and Young Adults from a Single Center in Turkey.
    Aykan HH; Karagoz T; Gulgun M; Ertugrul I; Aypar E; Ozer S; Alehan D; Celiker A; Ozkutlu S
    Pacing Clin Electrophysiol; 2016 Nov; 39(11):1225-1239. PubMed ID: 27620455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable cardioverter defibrillator therapy for prevention of sudden cardiac death in children in the Netherlands.
    Heersche JH; Blom NA; van de Heuvel F; Blank C; Reimer AG; Clur SA; Witsenburg M; ten Harkel AD
    Pacing Clin Electrophysiol; 2010 Feb; 33(2):179-85. PubMed ID: 20025697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Implantable Cardioverter Defibrillator Therapy with All-Cause Mortality-A Systematic Review and Meta-Analysis.
    Qian Z; Zhang Z; Guo J; Wang Y; Hou X; Feng G; Zou J
    Pacing Clin Electrophysiol; 2016 Jan; 39(1):81-8. PubMed ID: 26470761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
    JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.